1998
DOI: 10.1097/00001721-199803000-00011
|View full text |Cite
|
Sign up to set email alerts
|

The coagulation profile in hepatosplenic schistosomiasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

4
7
0

Year Published

2001
2001
2015
2015

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(11 citation statements)
references
References 0 publications
4
7
0
Order By: Relevance
“…It was reported that the progressive deterioration of liver function (matching the severity of the disease and the intensity of infection) led to a reduction in the blood levels of numerous coagulation proteins resulting in hypercoagulability and thrombin generation. This was subsequently followed by coagulation factor consumption, resulting in hypocoagulability and secondary fibrinolysis [12]. This last outcome is broadly akin to what is observed in this work: blood from 7-week infected mice forms strong clots much more rapidly than blood from controls but these clots are prone to break down very rapidly.…”
Section: Discussionsupporting
confidence: 54%
See 1 more Smart Citation
“…It was reported that the progressive deterioration of liver function (matching the severity of the disease and the intensity of infection) led to a reduction in the blood levels of numerous coagulation proteins resulting in hypercoagulability and thrombin generation. This was subsequently followed by coagulation factor consumption, resulting in hypocoagulability and secondary fibrinolysis [12]. This last outcome is broadly akin to what is observed in this work: blood from 7-week infected mice forms strong clots much more rapidly than blood from controls but these clots are prone to break down very rapidly.…”
Section: Discussionsupporting
confidence: 54%
“…A study of 14 patients (also with hepatosplenic schistosomiasis) likewise revealed that all coagulation parameters were significantly reduced in this group compared to healthy controls [11]. In another study, the coagulation profile of 60 schistosomiasis patients, with hepatosplenomegaly whose liver disease was graded least to worst, was compared with 15 healthy controls [12]. It was reported that the progressive deterioration of liver function (matching the severity of the disease and the intensity of infection) led to a reduction in the blood levels of numerous coagulation proteins resulting in hypercoagulability and thrombin generation.…”
Section: Discussionmentioning
confidence: 99%
“…Thus, kallikrein-like protease activity from S. mansoni adults [12] and plasmin-like fibrinolytic activity from S. mansoni eggs [15] have been recorded previously. Both activities displayed trypsin type cleavage specificities and both may contribute to the phenomenon, whereby large occlusions of veins by schistosomes are not associated with intravascular deposition of fibrin and thrombus formation [52]–[54]. At the gene and primary sequence levels, however, only two SmSPs, namely SmSP1 [13], [14] and another [23], [24], which we term SmSP2, have been described.…”
Section: Discussionmentioning
confidence: 99%
“…12 Low protein C activity has been described in patients with inflammatory hepatopathies, cirrhosis, portal venous obstruction, and infiltrative and neoplastic diseases and has been used as a prognostic indicator for monitoring hepatic transplant patients after surgery. [12][13][14][15][16][17] In our preliminary studies of protein C activity in dogs, we discovered that many dogs with acquired and congenital hepatobiliary disorders had low protein C activity and that dogs with PSS appeared to develop the lowest protein C activity. a The purpose of the study reported here was to evaluate the diagnostic use of protein C for detection of hepatobiliary disease and PSS in dogs.…”
mentioning
confidence: 99%